| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.5 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |